Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Six topics matched with clinical themes of the final indicator set.Topics of quality improvement projects, implemented by the NDPs (n)NDPs that implemented the project (n)Projects that intervened on specific quality prescribing Underprescribing of PPIs in patients using NSAIDsa6 Underprescribing of inhalation corticosteroids in patients with asthma5 Underprescribing of statins in patients with a history of cardiovascular diseasea4 Underprescribing of calcium and vitamin d in patients using bisphosphonates4 Underprescribing of vitamin D in patients aged over 70 years4 Therapeutic duplication of ACEi and AT-II antagonista6 Contra-indicated NSAIDS in patients with a history of cardiovascular diseasea8 Overuse of benzodiazepinesa4 Overuse of bisphosphonates4 Overuse of paracetamol-codeine1 Overprescribing of antidepressantsa1 Overprescribing of alpha-blockers in patients with LUTS6 Overprescribing of acetylsalicylic acid for primary cardiovascular risk prevention5 Overprescribing of inhalation corticosteroids in patients with COPD1 Overprescribing of triptans and starting preventive medication in patients with chronic migraine headache5 Overprescribing of PPIs3 Second-line antibiotics1 First-choice RAS-acting agents in new users1Projects that intervened on comprehensive quality prescribing Medication reconciliation after hospital discharge, taking all used medications into account5 Compliance with prescribing quality indicators measuring effective prescribing in primary care, defined by the Dutch Institute for Rational Use of Medicine (IVM)2Projects that intervened on organisation of care, underlying quality prescribing Optimise the organisation of referring to fellow GP with additional expertise in a specific (medication) field1 Optimise the exchange of information on medication prescriptions and medication lists between care providers2 Optimise registration of contra indications in the medical record1 Optimise the exchange of information on renal function between GP practice and community pharmacy1aTopic is represented in the eventual selection of quality prescribing indicators

Source: Fidelity of the intervention. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician’s prescribing, a non-randomised comparative study

Study design awaiting verification · International Journal of Clinical Pharmacy · 2020

Original publication title

Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician’s prescribing, a non-randomised comparative study

Vivianne M. Sloeserwij; Dorien L. M. Zwart; Ankie C. M. Hazen; Judith M. Poldervaart; Anne J. Leendertse; Antoinette A. de Bont; Marcel L. Bouvy; Niek J. de Wit; Han J. de Gier

© The Author(s) 2020

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: Electronic supplementary material

The online version of this article (10.1007/s11096-020-01075-4) contains supplementary material, which is available to authorized users.

Source: Electronic supplementary material
Authors’ abstract

Background Especially in elderly with polypharmacy, medication can do harm. Clinical pharmacists integrated in primary care teams might improve quality of pharmaceutical care. Objective To assess the effect of non-dispensing clinical pharmacists integrated in primary care teams on general practitioners’ prescribing quality. Setting This study was conducted in 25 primary care practices in the Netherlands. Methods Non-randomised, controlled, multi-centre, complex intervention study with pre-post comparison. First, we identified potential prescribing quality indicators from the literature and assessed their feasibility, validity, acceptability, reliability and sensitivity to change.

Also, an expert panel assessed the indicators’ health impact. Next, using the final set of indicators, we measured the quality of prescribing in practices where non-dispensing pharmacists were integrated in the team (intervention group) compared to usual care (two control groups). Data were extracted anonymously from the healthcare records. Comparisons were made using mixed models correcting for potential confounders. Main outcome measure Quality of prescribing, measured with prescribing quality indicators. Results Of 388 eligible indicators reported in the literature we selected 8.

In addition, two more indicators relevant for Dutch general practice were formulated by an expert panel. Scores on all 10 indicators improved in the intervention group after introduction of the non-dispensing pharmacist. However, when compared to control groups, prescribing quality improved solely on the indicator measuring monitoring of the renal function in patients using antihypertensive medication: relative risk of a monitored renal function in the intervention group compared to usual care: 1.03 (95% CI 1.01 to 1.05, p-value 0.010) and compared to usual care plus: 1.04 (1.01 to 1.06, p-value 0.004). Conclusion This study did not demonstrate a consistent effect of the introduction of non-dispensing clinical pharmacists in the primary care team on the quality of physician’s prescribing.

This study is part of the POINT-study, which was registered at The Netherlands National Trial Register with trial registration number NTR‐4389.

Electronic supplementary material

The online version of this article (10.1007/s11096-020-01075-4) contains supplementary material, which is available to authorized users.

Publication and source details

Original title: Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician’s prescribing, a non-randomised comparative study

Vivianne M. Sloeserwij; Dorien L. M. Zwart; Ankie C. M. Hazen; Judith M. Poldervaart; Anne J. Leendertse; Antoinette A. de Bont; Marcel L. Bouvy; Niek J. de Wit; Han J. de Gier

International Journal of Clinical Pharmacy · 2020

© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100007344AchmeaZ456Leendertse Anne J. http://dx.doi.org/10.13039/501100001826ZonMw80-833600-98-10206Leendertse Anne J.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T14:42:41.131596+00:00

DOI: 10.1007/s11096-020-01075-4 · PMC7522101